DiRocco Derek

Insider trading activity of DiRocco Derek

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Value · USD	Src
Acrivon Therapeutics, Inc.	Jun 22, 2026	AwardD	20,275	—	SEC
Acrivon Therapeutics, Inc.	May 20, 2026	Award	9,366	$0	SEC
Mineralys Therapeutics, Inc.	Feb 20, 2026	AwardD	8,300	$0	SEC
Mineralys Therapeutics, Inc.	Feb 20, 2026	Award	6,200	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-56,400	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-27,400	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-45,150	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-25,000	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-7,000	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-12,500	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-7,000	$0	SEC
Acrivon Therapeutics, Inc.	Jun 17, 2025	AwardD	20,275	$0	SEC
Mineralys Therapeutics, Inc.	Feb 24, 2025	AwardD	32,900	$0	SEC
89bio, Inc.	Feb 5, 2025	AwardD	56,400	$0	SEC
Acrivon Therapeutics, Inc.	Jun 24, 2024	AwardD	20,275	$0	SEC
Werewolf Therapeutics, Inc.	May 24, 2024	AwardD	17,500	$0	SEC
Mineralys Therapeutics, Inc.	May 23, 2024	AwardD	22,000	$0	SEC
89bio, Inc.	Feb 5, 2024	AwardD	45,150	$0	SEC
Werewolf Therapeutics, Inc.	Jun 23, 2023	AwardD	13,200	$0	SEC
iTeos Therapeutics, Inc.	Jun 15, 2023	AwardD	22,383	$0	SEC
89bio, Inc.	Feb 13, 2023	AwardD	27,400	$0	SEC
Mineralys Therapeutics, Inc.	Feb 13, 2023	AwardD	44,000	$0	SEC
Acrivon Therapeutics, Inc.	Nov 16, 2022	AwardD	35,235	$0	SEC
iTeos Therapeutics, Inc.	Jun 10, 2022	AwardD	17,538	$0	SEC
Werewolf Therapeutics, Inc.	Jun 3, 2022	AwardD	11,600	$0	SEC

Company	Filed	Type	Qty	Value · USD	Src
Acrivon Therapeutics, Inc.	Jun 22, 2026	AwardD	20,275	—	SEC
Acrivon Therapeutics, Inc.	May 20, 2026	Award	9,366	$0	SEC
Mineralys Therapeutics, Inc.	Feb 20, 2026	AwardD	8,300	$0	SEC
Mineralys Therapeutics, Inc.	Feb 20, 2026	Award	6,200	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-56,400	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-27,400	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-45,150	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-25,000	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-7,000	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-12,500	$0	SEC
89bio, Inc.	Oct 30, 2025	OtherD	-7,000	$0	SEC
Acrivon Therapeutics, Inc.	Jun 17, 2025	AwardD	20,275	$0	SEC
Mineralys Therapeutics, Inc.	Feb 24, 2025	AwardD	32,900	$0	SEC
89bio, Inc.	Feb 5, 2025	AwardD	56,400	$0	SEC
Acrivon Therapeutics, Inc.	Jun 24, 2024	AwardD	20,275	$0	SEC
Werewolf Therapeutics, Inc.	May 24, 2024	AwardD	17,500	$0	SEC
Mineralys Therapeutics, Inc.	May 23, 2024	AwardD	22,000	$0	SEC
89bio, Inc.	Feb 5, 2024	AwardD	45,150	$0	SEC
Werewolf Therapeutics, Inc.	Jun 23, 2023	AwardD	13,200	$0	SEC
iTeos Therapeutics, Inc.	Jun 15, 2023	AwardD	22,383	$0	SEC
89bio, Inc.	Feb 13, 2023	AwardD	27,400	$0	SEC
Mineralys Therapeutics, Inc.	Feb 13, 2023	AwardD	44,000	$0	SEC
Acrivon Therapeutics, Inc.	Nov 16, 2022	AwardD	35,235	$0	SEC
iTeos Therapeutics, Inc.	Jun 10, 2022	AwardD	17,538	$0	SEC
Werewolf Therapeutics, Inc.	Jun 3, 2022	AwardD	11,600	$0	SEC